Effect of probiotics on metabolic profiles in type 2 diabetes mellitus

Medicine (United States)

Volumn 95, Issue 26, 2016, Pages

  Li, Caifeng ^a   Li, Xin ^b   Han, Hongqiu ^b   Cui, Hailong ^a   Peng, Min ^a   Wang, Guolin ^a   Wang, Zhiqiang ^a  

^a Intensive Care Unit   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBIOTIC AGENT; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; COCHRANE LIBRARY; DIET RESTRICTION; DRUG EFFECT; EMBASE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUPPLEMENTATION; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; DIET THERAPY; METABOLISM;

DIABETES MELLITUS, TYPE 2; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85013799318     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004088     Document Type: Article

References (53)

1. Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-49
2. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-70
3. Lefèbvre P, Pierson A. The global challenge of diabetes. World Hosp &Health Serv the Official Journal of the International Hospital Federation 2004;40:37-40, 42
4. Hansen AK, Hansen CHF, Krych L, et al. Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol 2014;20:17727
5. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65
6. Bienenstock J, Kunze W, Forsythe P. Microbiota and the gut-brain axis. Nutr Rev 2015;73(suppl 1):28-31
7. Panwar H, Rashmi HM, Batish VK, et al. Probiotics as potential biotherapeutics in the management of type 2 diabetes-prospects and perspectives. Diabetes Metab Res Rev 2013;29:103-12
8. Delzenne NM, Cani PD. Gut microflora is a key player in host energy homeostasis. Med Sci 2008;24:505-10
9. Larsen N, Vogensen FK, Berg FWJ, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One 2010;5:e9085-19085
10. Lê K-A, Li Y, Xu X, et al. Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population. Front Physiol 2012;3:496-1496
11. Joint FAO.WHOWorking Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada, April 30 and May 1, 2002. 2014
12. Szajewska H, Skórka a , Ruszczynski M, et al. Meta-analysis: lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Thers 2007;25:871-81
13. Onge M-P, Farnworth ER, Savard T, et al. Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial [ISRCTN10820810]. BMC Complement Altern Med 2002;2: 1-1
14. Ooi L-G, Liong M-T. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 2010;11:2499-522
15. Begley M, Hill C, Gahan CGM. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 2006;72:1729-38
16. Patel AK, Singhania RR, Pandey A, et al. Probiotic bile salt hydrolase: current developments and perspectives. Appl Biochem Biotechnol 2010;162:166-80
17. Guo Z, Liu XM, Zhang QX, et al. Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 2011;21:844-50
18. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003;37:343-50
19. Tabuchi M, Ozaki M, Tamura A, et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2003;67:1421-4
20. Kootte RS, Vrieze A, Holleman F, et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obesity Metab 2012;14:112-20
21. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Int Med 2009;151:264-264
22. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Vol 4. John Wiley &Sons; 2011
23. Hosseinzadeh P, Djazayery A, Mostafavi SA, et al. Brewer's yeast improves blood pressure in type 2 diabetes mellitus. Iran J Public Health 2013;42:602-9. http://www.pubmedcentral.nih.gov/articlerenderhttp:// www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3744257andtool= pmcentrezandrendertype=abstract
24. Tajadadi-Ebrahimi M, Bahmani F, Shakeri H, et al. Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: a doubleblind, randomized, controlled clinical trial. Ann Nutr Metab 2014;65: 34-41
25. Hove KD, Brons C, Faerch K, et al. Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled study. Eur J Endocrinol 2015;172: 11-20
26. Firouzi S, Majid HA, Ismail A, et al. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial. Eur J Nutr 2016;[Epub ahead of print]
27. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad S A. , et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011;94:3288-94
28. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, et al. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012; 28:539-43
29. Hosseinzadeh P, Javanbakht MH, Mostafavi S-A, et al. Brewer's yeast improves glycemic indices in type 2 diabetes mellitus. Int J Prev Med 2013;4:1131-8
30. Asemi Z, Zare Z, Shakeri H, et al. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 2013;63:1-9
31. Shakeri H, Hadaegh H, Abedi F, et al. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids 2014;49:695-701
32. Mohamadshahi M, Veissi M, Haidari F, et al. Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: a randomized controlled clinical trial. J Res Med Sci 2014;19:531-6
33. Bayat A, Azizi-Soleiman F, Heidari-Beni M, et al. Effect of cucurbita ficifolia and probiotic yogurt consumption on blood glucose, lipid profile, and inflammatory marker in type 2 diabetes. Int J Prev Med 2016;7:30
34. Mazloom Z, Yousefinejad A, Dabbaghmanesh MH. Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial. Iran J Med Sci 2013;38:38-43
35. Seino Y, Nanjo K, Tajima N, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010;1:212-28
36. Toth PP, Zarotsky V, Sullivan JM, et al. Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis. Cardiovasc Diabetol 2009;8:26-126
37. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-72
38. Amyot J, Semache M, Ferdaoussi M, et al. Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-Like Receptor-4 and NF-kB signalling. PloS One 2012;7:e36200-136200
39. Festa a , D'Agostino R, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7
40. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012;489:242-9
41. Konstantinov SR, Smidt H, de Vos WM, et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci USA 2008;105:19474-9
42. Ouwehand AC, Tiihonen K, Saarinen M, et al. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 2009;101:367-75
43. Wang YC, Yu RC, Chou CC. Antioxidative activities of soymilk fermented with lactic acid bacteria and bifidobacteria. Food Microbiol 2006;23:128-35
44. Lin MY, Chang FJ. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci 2000;45:1617-22
45. Rumbak I, Bituh M, Keser I, et al. The relationship between milk and milk products consumption and blood lipid profile in women. J Hygienic Eng Design 2014;8:37-43
46. Agerbaek M, Gerdes LU, Richelsen B. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 1995;49:346-52
47. St-Onge MP, Farnworth ER, Jones PJ. Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. Am J Clin Nutr 2000;71:674-81
48. Zhuang G, Liu X-M, Zhang Q-X, et al. Research advances with regards to clinical outcome and potential mechanisms of the cholesterol-lowering effects of probiotics. Clin Lipidol 2012;7:501-7
49. Kiessling G, Schneider J, Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 2002;56:843-9
50. Smedman aE , Gustafsson IB, Berglund LG, et al. Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 1999;69:22-9
51. Ruan Y, Sun J, He J, et al. Effect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, controlled trials. Plos One 2015;10: e0132121
52. Sun J, Buys NJ. Glucose-and glycaemic factor-lowering effects of probiotics on diabetes: a meta-analysis of randomised placebo-controlled trials. Brit J Nutr 2016;115:1167-77
53. Kasinska MA, Drzewoski J. Effectiveness of probiotics in type 2 diabetes: a meta-analysis. Polskie Archiwum Medycyny Wewnetrznej 2015;125: 803-13